2 line items calcitonin gene-related peptides (CGRP) awarded for a base year period of 2/26/2025 to 2/25/2026 plus four one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0009
- Awardee
-
Amgen USA Inc. UEI XPGNQMXHP493
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--CGRP Calcitonin Gene-Related Peptides Pre-Solicitation · 36E79724R0030 · Posted Sep 25, 2024
- Last date to order 85% complete
- IDV ceiling
- $100,527,333.60
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Amgen USA Inc. for calcitonin gene-related peptide (CGRP) products, with a ceiling value of $100,527,333.60, effective February 26, 2025.
The contract covers two line items of CGRP agents for a base year period from February 26, 2025 through February 25, 2026, plus four one-year option periods, with ultimate completion on February 25, 2027. Place of performance encompasses the VA, including its Consolidated Mail Outorder Pharmacies and State Veterans Homes, Indian Health Service, and Federal Health Care Center. Products will be distributed through the VA's and Department of Defense Pharmaceutical Prime Vendor Programs.
The originating solicitation, posted as a pre-solicitation on September 25, 2024, solicited unrestricted procurement of CGRP products available to all responsible sources. Offerors were required to provide a unique National Drug Code number and label for their product. The NAICS code is 325412 (pharmaceutical preparation manufacturing). The request for proposal was scheduled for issuance on or about October 10, 2024, with a tentative closing date of October 24, 2024.
A modification to the contract incorporated clause 52.222-90 implementing Executive Order 14398.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0009?
36E79725D0009 was awarded to Amgen USA Inc. by National Acquisition Center (Headquarters) on February 26, 2025.
How much is contract 36E79725D0009 worth?
36E79725D0009's own ceiling is $100,527,334.
Who can order from contract 36E79725D0009?
36E79725D0009 is a single award indefinite delivery contract.
Was contract 36E79725D0009 competed?
The extent of competition for 36E79725D0009 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV